Just over a decade after the sale of the Piramal group’s formulations business to Abbott Laboratories Inc., chairman Ajay Piramal has stitched up another profitable deal. Piramal Enterprises Ltd. (PEL) is selling its stake in fully owned Decision Resources Group (DRG), a healthcare research and consulting company, to Clarivate Analytics Plc for $950m.
The divestment gives PEL $900m in cash and an undefined stake in Clarivate worth $50m post a year of the...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
